Mega Genomics Ltd
06667
Company Profile
Business description
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services, ancillary services, and related products in the PRC. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening, and infectious disease diagnosis, to meet consumers' growing preventive medical needs. It generates a majority of its revenue from consumer genetic testing services.
Contact
North Garden Road
401 Health Work
Haidian District
Beijing
CHNSector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
206
Stocks News & Analysis
stocks
Are ASX REITs the better way to own property?
Cheap valuations, strong yields and a changing Aussie property landscape.
stocks
Cheap Dividend Aristocrat has Fair Value raised after earnings
Dividend forecasts raised after balance sheet regains strength.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,283.10 | 14.50 | 0.16% |
| CAC 40 | 8,579.60 | 57.19 | -0.66% |
| DAX 40 | 26,338.61 | 101.70 | -0.38% |
| Dow JONES (US) | 53,459.78 | 272.63 | -0.51% |
| FTSE 100 | 10,720.30 | 29.81 | -0.28% |
| HKSE | 25,453.23 | 336.38 | 1.34% |
| NASDAQ | 26,644.91 | 84.25 | -0.32% |
| Nikkei 225 | 68,998.33 | 221.92 | -0.32% |
| NZX 50 Index | 13,743.80 | 21.82 | 0.16% |
| S&P 500 | 7,745.06 | 40.70 | -0.52% |
| S&P/ASX 200 | 9,075.90 | 11.10 | 0.12% |
| SSE Composite Index | 3,982.65 | 55.48 | 1.41% |